AQR International Probability of Target Price Finishing Over Current Price

ANDRX -- USA Fund  

USD 13.41  0.10  0.75%

AQR International probability of target price tool provides mechanism to make assumptions about upside and downside potential of AQR International Defensive Style R6 performance during a given time horizon utilizing its historical volatility. Please specify AQR International time horizon, a valid symbol (red box) and a target price (blue box) you would like AQR International odds to be computed. Check also AQR International Backtesting, Portfolio Optimization, AQR International Correlation, AQR International Hype Analysis, AQR International Volatility, AQR International History as well as AQR International Performance.
Horizon     30 Days    Login   to change
Symbol:
Refresh Odds

AQR International Target Price Odds to finish over

Current PriceHorizonTarget PriceOdds to move above current price in 30 days
 13.41 30 days 13.41  ABOUT 7.39%
Based on normal probability distribution, the odds of AQR International to move above current price in 30 days from now is about 7.39% (This AQR International Defensive Style R6 probability density function shows the probability of AQR International Fund to fall within a particular range of prices over 30 days) .
Assuming 30 trading days horizon, AQR International has beta of 0.4438 . This suggests as returns on market go up, AQR International average returns are expected to increase less than the benchmark. However during bear market, the loss on holding AQR International Defensive Style R6 will be expected to be much smaller as well. Additionally AQR International Defensive Style R6 has a negative alpha implying that the risk taken by holding this equity is not justified. The company is significantly underperforming DOW
 AQR International Price Density 
 
      
Current Price   Target Price   
α
Alpha over DOW
=0.03
β
Beta against DOW=0.44
σ
Overall volatility
=0.15
Ir
Information ratio =0.21

AQR International Alerts

AQR International Alerts and Suggestions

Latest headline from www.thewellesleysnews.com: Analyst Research and Ratings Crinetics Pharmaceuticals, Inc. , Qwest Corp. NT 100154
The fund holds 93.91% of its assets under management (AUM) in equities

Price Density Drivers

AQR International Health Indicators

Check also AQR International Backtesting, Portfolio Optimization, AQR International Correlation, AQR International Hype Analysis, AQR International Volatility, AQR International History as well as AQR International Performance. Please also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.
Search macroaxis.com